Model of robust induction of glomerulosclerosis in mice: Importance of genetic background

Kidney International

Volumn 64, Issue 1, 2003, Pages 350-355

  Ma, Li Jun ^a   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

129 Sv; C57BL 6; Hypertension; Kidney

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; GENETIC SUSCEPTIBILITY; GENETICS; GLOMERULOSCLEROSIS; KIDNEY FIBROSIS; MALE; MOUSE; MOUSE STRAIN; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 0038129781     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00058.x     Document Type: Article

References (31)

1. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
2. SHIMAMURA T, MORRISON AB: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79:95-106, 1975
3. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
4. GRIFFIN KA, PICKEN M, BIDANI AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4:2023-2031, 1994
5. IBRAHIM HN, HOSTETTER TH: The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol 9:72-76, 1998
6. INGLIS JA, HALLIDAY JW: Renal damage after subtotal nephrectomy. Pathol 1:177-183, 1969
7. AL BANCHAABOUCHI M, MARESCAU B, D'HOOGE R, et al: Biochemical and histopathological changes in nephrectomized mice. Metabolism 47:355-361, 1998
8. KREN S, HOSTETTER TH: The course of the remnant kidney model in mice. Kidney Int 56:333-337, 1999
9. MATSUYAMA M, OGIU T, KONTANI K, et al: Genetic regulation of the development of glomerular sclerotic lesions in the BUF/Mna rat. Nephron 54:334-337, 1990
10. GROND J, BEUKERS JY, SCHILTHUIS MS, et al: Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis. Lab Invest 54:77-83, 1986
11. HE C, ESPOSITO C, PHILLIPS C, et al: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97:1242-1249, 1996
12. ZHENG F, STRIKER GE, ESPOSITO C, et al: Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 54:1999-2007, 1998
13. ESPOSITO C, HE C-J, STRIKER GE, et al: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 154:891-897, 1999
14. FUJII M, HARA H, MENG W, et al: Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28:1805-1811, 1997
15. KUHEL DG, ZHU B, WITTE DP, HUI DY: Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol 22:955-960, 2002
16. PAIGEN B, ISHIDA BY, VERSTUYFT J, et al: Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10:316-323, 1990
17. SMITH JD, JAMES D, DANSKY HM, et al: In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 23:117-122, 2003
18. BIDANI AK, MITCHELL KD, SCHWARTZ MM, et al: Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. Kidney Int 38:28-38, 1990
19. BIDANI AK, GRIFFIN KA, PLOTT W, SCHWARTZ MM: Genetic predisposition to hypertension and microvascular injury in the remnant kidney model. J Lab Clin Med 122:284-291, 1993
20. CHURCHILL PC, CHURCHILL MC, GRIFFIN KA, et al: Increased genetic susceptibility to renal damage in the stroke-prone spontaneously hypertensive rat. Kidney Int 61:1794-1800, 2002
21. MEGYESI J, PRICE PM, TAMAYO E, SAFIRSTEIN RL: The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA 96:10830-10835, 1999
22. WANG Q, HUMMLER E, NUSSBERGER J, et al: Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: Role of renin genes. J Am Soc Nephrol 13:1509-1516, 2002
23. GRIFFIN KA, PICKEN MM, CHURCHILL M, et al: Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 11:497-506, 2000
24. IBRAHIM HN, ROSENBERG ME, GREENE EL, et al: Aldosterone is a major factor in the progression of renal disease. Kidney Int 52(Suppl 63):S115-S119, 1997
25. ROSENBERG ME, CORREA-ROTTER R, INAGAMI T, et al: Glomerular renin synthesis and storage in the remnant kidney in the rat. Kidney Int 40:677-683, 1991
26. FOGO AB: Progression and potential regression of glomerulosclerosis (Nephrology Forum). Kidney Int 59:804-819, 2001
27. MA L-J, FOGO AB: Role of angiotensin II in glomerular injury. Semin Nephrol 21:544-553, 2001
28. BROWN NJ, VAUGHAN DE, FOGO AB: The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol 22:399-406, 2002
29. LEWIS EJ, HUNSICKER LG, CLARKE WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
30. BRENNER BM, COOPER ME, DE ZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
31. PARVING HH, LEHNERT H, BROCHNER-MORTENSEN J, et al: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001